Post-procedural pain medication gets label extension from the FDAApril 12, 2024An extended-release buprenorphine injectable suspension indicated for mice, rats, ferrets, Ethiqa XR gets the U.S. Food and Drug Administration (FDA) green light for use in non-human primates (NHPs)
SPONSORED CONTENTLife-saving results for parvovirus casesResearch has shown that puppies treated with our Canine Parvovirus Monoclonal Antibody have shorter clinic stays.1 Transform parvo treatment outcomes for your patients. + Read More